Early postoperative serum metal profiles and subsequent revision-related surgery after instrumented fusion for adolescent idiopathic scoliosis
International Orthopaedics · 2026-12 · 50 (12) · 3251-3262
DOI: 10.1007/s00264-026-07021-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Orthopaedics, online erschienen am 15.09.2026. Verfasst von Tao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. Hauptthemen laut MEDLINE: Scoliosis, Spinal Fusion, Cobalt, Titanium. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
BACKGROUND: Circulating titanium (Ti), cobalt (Co), and chromium (Cr) can increase after spinal instrumentation for adolescent idiopathic scoliosis (AIS), but their relation to later revision surgery is uncertain. METHODS: This was a single-centre retrospective prognostic model-development study with a six month landmark. The cohort comprised 154 patients with AIS who underwent posterior instrumented fusion and had serum Ti, Co, and Cr measured at one and six months. Only revision-related procedures performed after six months were counted as outcomes. Log₂-transformed metal concentrations were examined in prespecified logistic models. Performance was assessed by AUC, Brier score, calibration, decision curve analysis, and risk-stratum event rates. Internal validation used 1000 bootstrap resamples to estimate optimism-corrected AUCs and Brier scores. RESULTS: Sixty patients underwent later revision-related surgery and 94 did not. Ti and Co were higher in the revision group, with the largest difference for Ti at one month. The primary one month Ti/Co/Cr model had an apparent AUC of 0.926 and an optimism-corrected AUC of 0.918. The corresponding Brier scores were 0.099 and 0.108. Revision rates across predicted-risk were 3.8%, 23.5%, and 90.2%. In a sensitivity analysis restricted to implant loosening, the optimism-corrected AUC was 0.876. CONCLUSIONS: Early postoperative serum metal profiles were associated with later revision-related surgery after AIS fusion. The one month Ti/Co/Cr model provided the most favourable balance between early availability, parsimony, and discrimination. Its clinical utility requires external validation and comparison with conventional clinical and imaging predictors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
- Department of General Surgery, Second Xiangya Hospital of Central South University, Changsha, China.
- Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Multimodal Oncology, Changsha Medical University, Changsha, 410219, Hunan, China.
- College of Medicine, Nursing and Health Sciences, Ollscoil na Gaillimhe - University of Galway, Galway, Ireland. s.li14@universityofgalway.ie.
Förderung
- Natural Science Foundation of Hunan Province
Zitieren
APA
Li, T., Alonge, E., Ye, F., Liu, L., & Li, S. (2026). Early postoperative serum metal profiles and subsequent revision-related surgery after instrumented fusion for adolescent idiopathic scoliosis. International Orthopaedics, 50(12), 3251-3262. https://doi.org/10.1007/s00264-026-07021-9
Vancouver
Li T, Alonge E, Ye F, Liu L, Li S. Early postoperative serum metal profiles and subsequent revision-related surgery after instrumented fusion for adolescent idiopathic scoliosis. International Orthopaedics. 2026;50(12):3251-3262. doi:10.1007/s00264-026-07021-9
BibTeX
@article{Li2026,
author = {Li, Tao and Alonge, Emmanuel and Ye, Fei and Liu, Lili and Li, Sha},
title = {Early postoperative serum metal profiles and subsequent revision-related surgery after instrumented fusion for adolescent idiopathic scoliosis},
journal = {International Orthopaedics},
year = {2026},
volume = {50},
number = {12},
pages = {3251--3262},
doi = {10.1007/s00264-026-07021-9}
}
EUVIMED